NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).

Garmin (NasdaqNM: GRMN) closed yesterday at $30.86. So far the stock has hit a 52-week low of $14.40 and 52-week high of $39.65. Garmin stock has been showing support around 29.93 and resistance in the 31.97 range. Technical indicators for the stock are Bearish and S&P gives GRMN a neutral 3 STAR (out of 5) ...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

TomTom shares have lost their sense of direction over the last month, with the stock down by more than a third, as worries about competition and third-quarter earnings lead the stock off route.

Garmin (NasdaqNM: GRMN) closed yesterday at $32.48. So far the stock has hit a 52-week low of $14.40 and 52-week high of $39.65. Garmin stock has been showing support around 31.63 and resistance in the 32.91 range. Technical indicators for the stock are Bullish and S&P gives GRMN a neutral 3 STAR (out of 5)...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)

Garmin (NasdaqNM: GRMN) closed yesterday at $32.33. So far the stock has hit a 52-week low of $14.40 and 52-week high of $39.65. Garmin stock has been showing support around 31.32 and resistance in the 32.88 range. Technical indicators for the stock are Bullish and S&P gives GRMN a neutral 3 STAR (out of 5)...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)

Dr Stock Pick HOT News & Alerts! _________________________________________ FREE Daily Stock Alerts From DrStockPick.com _________________________________________ DrStockPick.com Watch List! My Picks for Tuesday November 17, 2009 are: ************************************************************** NGSX, NeurogesX, Inc. NGSX is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. ** The U.S. Food and Drug Administration (FDA) has approved NGSX’s Qutenza(TM) (capsaicin) 8% patch, the first and only product [...]

On the second Thursday of every month (I know, I’m a day late…), we will screen our database for the 10 companies trading at the lowest ratio to their intrinsic value, as determined by our formula, and that are suitable for the enterprising investor.  These 10 companies will be placed in a mock portfolio and [...] Related posts:

1. Low PE Portfolio – October 2009 Update On the first Tuesday of every month, we will screen...
2. Dividend Portfolio – October 2009 Update On the first Friday of every month, we will screen...
3. Enterprising Value Portfolio – 10 Undervalued Companies for the Enterprising Investor On the second Thursday of every month, we will screen...

Related posts brought to you by Yet Another Related Posts Plugin.

In the last few days short interest on Garmin has been on the decline. So is its stock price over a month (down 21.6%) and three months (down 10.28%) periods. It has almost most the gains made during May –July period. How does its outlook seem?[More...]

Garmin Ltd. (GRMN) reported third quarter earnings that beat the Zacks Consensus Estimate by 32 cents. Fully diluted pro forma earnings per share (EPS) were $1.01, compared to 83 cents in the June quarter and 88 cents in the comparable prior-year quarter. The pro forma number excludes a foreign currency gain in the last quarter. Revenue Revenue [...]

(GRMN) Garmin Limited Reports Robust Earnings Quarter

BloggingStocks: Here are some highlights from last week's earnings coverage from BloggingStocks: CBS Corp. (NYSE: CBS) reported that Q3 revenue was flat while earnings and cash flow declined. Clorox Co. (NYSE: CLX) reported better-than-expected Q1 earnings, ... Read more

Schaeffer's analyst Morgan Searcy takes a look at news on the Street before the market open.

Tom Dorsey and Tammy DeRosier - Back to Reality

Schaeffer's analyst Morgan Searcy takes a look at news on the Street before the market open.

Schaeffer's analyst Morgan Searcy takes a look at news on the Street before the market open.

Tom Dorsey and Tammy DeRosier - Interstate 95 South